Ravi Mani, a board certified gastroenterologist at Bay Area Gastroenterology, explains that while colon cancer is a preventable disease, it remains the second most common cancer in the U.S. and causes an estimated 60,000 deaths every year. Dr. Mani and his colleagues hope that by educating the public on the dietary and lifestyle changes that can reduce risks, along with the screening options available today, this number will drop in the years to come. Now along with a complete colonoscopy, a new Virtual Colonoscopy is providing a less invasive option and eliminating the need for sedation.The virtual colonoscopy creates a computer generated 3-D rendering of the colon without the use of a scope. Among the first in the Bay area and greater Houston area to offer this new colon cancer screening technology, the group of board certified gastroenterology physicians also offer Sigmoidoscopy, which is similar to a colonoscopy but examines only the lower part of the colon, and a Fecal Occult Blood Test, which tests a stool sample to determine if there is bleeding within the digestive tract. “We have a number of early screening options for patients.It has never been easier to identify precancerous polyps and completely prevent colon cancer from developing into a life threatening disease,” said Dr. Mani. “Unfortunately many believe if there are no symptoms, screening is unnecessary.But the vast majority have no symptoms and 70 percent of those diagnosed each year have no family history either,” added Dr. Mani. Colorectal screening is recommended for those 50 years old or older (age 45 for African Americans) and every ten years following that if no polyps or irregularities are found. And according to a study published by the British Medical Journal, everyone can lower their risk of colorectal cancer by following healthy lifestyle habits and exercising more than 30 minutes a day. The gastroenterology consultants are part of Bay Area Gastroenterology in Clear Lake, which was the first Houston gastroenterology and endoscopy practice to offer office based accredited Virtual colonoscopy screening.They specialize in the diagnosis and treatment of ailments of the stomach, intestines, colon, liver, gallbladder and pancreas.
Carroll County Gastroenterology Selects Benchmark for Practice Management Solution
Dr. Michael R. Bowen, who is board-certified in both Internal Medicine and Gastroenterology, treats patients with a wide range of digestive symptoms and disorders. Carroll County Gastroenterology also offers a licensed Ambulatory Surgical Center providing professional care such as colonoscopies, upper endoscopies, liver biopsys and infusion therapies. For additional information go online to http://www.cc-gi.com. About Benchmark Systems Inc. Benchmark is a leading Internet based provider of fully integrated solutions that automates all of the clinical and business functions required for healthcare providers. Benchmark offers seamless integrated Patient Portals, Personal Health Records, Scheduling, EMR, Billing, Messaging, Fax, CPOE, Rx Scripting, and Revenue Cycle Management at an affordable monthly fee. Recognized for their use of leading edge cloud based technology, Benchmarks suite of software was built leveraging over 35 years of expertise in helping healthcare providers solve profitability and limited time issues. For more information about Benchmark Systems please call us at 1.800.779.0902 or visit us online at http://www.benchmark-systems.com. Benchmarks reputation in the marketplace is built on providing quality products and services that exceed expectations to todays most sophisticated clinics.
CORPAK Acquires Merck Serono’s UK Gastroenterology Sales and Distribution Operation
Finance Tue, Sep 3, 2013, 9:43 AM EDT – U.S. Markets close in 6 hrs 17 mins Stock Watch CORPAK Acquires Merck Serono’s UK Gastroenterology Sales and Distribution Operation Press Release: Mergers and Acquisitions Tue, Oct 2, 2012 8:00 AM EDT Print Related Content BUFFALO GROVE, IL–(Marketwire – Oct 2, 2012) – CORPAK MedSystems, Inc., a leading developer, manufacturer, and marketer of medical devices for the enteral-feeding and bedside-location markets, today announced it will acquire the gastroenterology sales and distribution operation of Merck Serono Limited in the UK and Ireland. Merck Serono had previously served as CORPAK’s distribution partner for the region. “The acquisition of the Merck Serono gastroenterology business strengthens our presence in Europe and our direct operation will support high levels of customer service and continued growth,” says Tom Kuhn, President of CORPAK. “I would like to thank the employees at Merck Serono for their support in building the CORPAK business in the UK and Republic of Ireland.” “The gastroenterology business is a strong and growing operation in the UK and Ireland, but Merck Serono has made a strategic decision to focus on our core pharmaceutical business,” explains Charles Dring, Commercial Director of Merck Serono Limited. “We have been working very closely with CORPAK to make the transition as seamless as possible for our customers.” There will be no change to the product range and all CORPAK products will continue to be available on the current codes and prices. The acquisition keeps relationships with existing sub-distributors unchanged. “We are especially pleased to be able to welcome the gastroenterology employees from Merck Serono to the CORPAK family,” says Jeff Blair, CEO of CORPAK. “We are confident that the UK and Ireland team will continue the history of excellence and dedication that has benefitted our customers in the past.” “This acquisition represents an important step in expanding our international presence and we look forward to continuing to provide our innovative, quality products to the European market,” added Eric Larson, Chairman of the CORPAK Board. CORPAK MedSystems UK ( http://www.corpakmedsystemsuk.com )